MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD – Get Free Report) shares dropped 8.2% during trading on Tuesday . The stock traded as low as $0.42 and last traded at $0.44. Approximately 559,415 shares traded hands during trading, an increase of 317% from the average daily volume of 134,123 shares. The stock had previously closed at $0.48.
MyMD Pharmaceuticals Stock Down 8.2 %
The stock has a fifty day simple moving average of $1.00 and a 200 day simple moving average of $1.33.
MyMD Pharmaceuticals Company Profile
MyMD Pharmaceuticals, Inc, a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the aging and age-related and autoimmune diseases, and chronic pain, anxiety, and sleep disorders. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system and its pro-inflammatory cytokines to prevent and treat autoimmune diseases and age-related illnesses, and a Phase 2 clinical trial for sarcopenia, multiple sclerosis, diabetes, inflammatory bowel diseases, and rheumatoid arthritis; inflammation related depression and anxiety; and COVID-19-associated depression.
Featured Articles
- Five stocks we like better than MyMD Pharmaceuticals
- Transportation Stocks Investing
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- Comparing and Trading High PE Ratio Stocks
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Are Penny Stocks a Good Fit for Your Portfolio?
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for MyMD Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MyMD Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
